Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 26, 2022

Toxicity Index, Patient-Reported Outcomes, and Persistence of Chemotherapy-Associated Adverse Effects in Patients With Breast Cancer

NPJ breast cancer


Additional Info

NPJ breast cancer
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30
NPJ Breast Cancer 2022 Nov 19;8(1)123, NL Henry, S Kim, RD Hays, MA Diniz, M Tighiouart, G Gresham, M Luu, RS Cecchini, G Yothers, A Rogatko, PA Ganz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading